IP Library › Assignment 052340/0927
Patent Assignment
Reel/Frame 052340/0927

Assignment of Assignor's Interest

Recorded: 2020-04-08 Pages: 10
Assignor
GANYMED PHARMACEUTICALS AG
Executed: 2017-03-22
Assignee
GANYMED PHARMACEUTICALS GMBH
AN DER GOLDGRUBE 12, MAINZ, 55131, GERMANY
Covered Property (1)
Cancer Therapy Using CLDN6 Target-Directed Antibodies in Vivo
Patent: 9,718,886 →
Application: 13/808,423 →
Publication: US 2013/0183305
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 18, 2013
From: SAHIN, UGUR; TURECI, OZLEM; KOSLOWSKI, MICHAEL; WALTER, KORDEN
To: GANYMED PHARMACEUTICALS AG; JOHANNES GUTENBERG-UNIVERSITAT MAINZ
Reel/Frame 030032/0621 →
Corrective Assignment to Correct the First Assignee Data Previously Recorded at Reel: 030032 Frame: 0621. Assignor(S) Hereby Confirms the Assignment. Aug 10, 2016
From: SAHIN, UGUR; TURECI, OZLEM; KOSLOWSKI, MICHAEL; WALTER, KORDEN
To: GANYMED PHARMACEUTICALS AG; JOHANNES GUTENBERG-UNIVERSITAT MAINZ
Reel/Frame 039641/0343 →